Acta Neurologica Scandinavica

The new cholesterol controversy - a little bit of history repeating?
pp. 1-2(2)

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
pp. 3-7(5)
Authors: Sparks, D. L.; Connor, D. J.; Sabbagh, M. N.; Petersen, R. B.; Lopez, J.; Browne, P.

Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology
pp. 8-14(7)
Authors: Mahley, R. W.; Huang, Y.

Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease
pp. 15-20(6)
Authors: Laskowitz, D. T.; Fillit, H.; Yeung, N.; Toku, K.; Vitek, M. P.

Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
pp. 21-26(6)
Author: Michikawa, M.

Altered membrane fluidity and lipid raft composition in presenilin-deficient cells
pp. 27-32(6)
Authors: Grimm, M. O. W.; Tschäpe, J.-A.; Grimm, H. S.; Zinser, E. G.; Hartmann, T.

Cholesterol metabolism in the brain: importance of 24S-hydroxylation
pp. 33-42(10)
Authors: Lütjohann, D.

Oxysterols and Alzheimer's disease
pp. 43-49(7)
Authors: Björkhem, I.; Heverin, M.; Leoni, V.; Meaney, S.; Diczfalusy, U.

Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence
pp. 50-57(8)
Authors: Kivipelto, M.; Solomon, A.

The lower the better? Experiences from cardiovascular disease and stroke prevention
pp. 58-62(5)
Author: Olsson, A. G.

Re-assessing the relationship between cholesterol, statins and Alzheimer's disease
pp. 63-70(8)
Authors: Wolozin, B.; Manger, J.; Bryant, R.; Cordy, J.; Green, R. C.; McKee, A.

Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease
pp. 71-77(7)
Author: Rockwood, K.

Statin therapy in Alzheimer's disease
pp. 78-86(9)
Authors: Sparks, D. L.; Sabbagh, M.; Connor, D.; Soares, H.; Lopez, J.; Stankovic, G.; Johnson-Traver, S.; Ziolkowski, C.; Browne, P.

Effect of statins on β-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease
pp. 87-92(6)
Authors: Höglund, K.; Wallin, A.; Blennow, K.

Cholesterol, statins and tau
pp. 93-101(9)
Authors: Ohm, T. G.; Meske, V.

Inflammation and dementia: epidemiologic evidence
pp. 102-106(5)
Authors: Peila, R.; Launer, L. J.

In vivo evidence for microglial activation in neurodegenerative dementia
pp. 107-114(8)
Authors: Cagnin, A.; Kassiou, M.; Meikle, S. R.; Banati, R. B.

The role of pleiotropic effects of statins in dementia
pp. 115-118(4)
Author: Crisby, M.

Alzheimer's Disease: back to the future
pp. 119-120(2)
Authors: Kivipelto, M.; Solomon, A.; Winblad, B.